The senior was prescribed metoclopromide, which the lawsuit alleges is known to make the disease worse.
A Vernon College senior is suing a doctor who prescribed a drug that significantly worsened his Parkinson’s disease symptoms, leaving him confined to a wheelchair and dependent on a feeding tube.
Sharon Wright arrived at Vernon Jubilee Hospital on February 10, 2022, complaining of mild symptoms of Parkinson’s disease, including a slouched posture, slow walking, nausea, and loss of appetite.
Wright was given metoclopromide (Maxellan) on February 24 to treat nausea. Her condition quickly deteriorated and by March 1st she was unable to swallow and required tube feeding and she was transferred to Kelowna General Hospital where she was hospitalized on March 5th. I was hospitalized. She stopped taking medicine.
Mr. Wright filed a notice of civil action in British Columbia Supreme Court against four doctors: Gideon Lamprecht, Caitlin Holtby, Elsadig Elamin and Scott Meckling.
According to the civil notice of claim, the basis of the lawsuit is that the defendants should have known that metoclopramide was contraindicated in patients with Parkinson’s disease, meaning that it should not be given to these patients.
“Defendants knew, or should have known, that metoclopramide could cause patients to develop Parkinson’s disease, which mimics Parkinson’s disease but does not respond to dopamine therapy to the same extent as idiopathic Parkinson’s disease. was.”
As a result of doctors’ “neglect,” Mr. Wright’s nervous system rapidly deteriorated, he required a feeding tube due to an inability to swallow, lost significant weight, became wheelchair-bound with reduced mobility, and suffered from depression and anxiety. He claims to have fallen ill.
Mr. Wright is seeking general damages, an in-trust claim against his family, special damages, past and future medical expenses, interest and costs.
In addition to prescribing Wright with contraindicated medications, the lawsuit alleges that doctors failed to properly evaluate Wright’s underlying medical conditions.
“Defendants argue that because metoclopramide’s side effects include the development of extrapyramidal disease as a side effect of drug therapy, it is not suitable for patients suffering from extrapyramidal disease in the form of Parkinson’s disease, parkinsonism, dyskinesia, or dystonia. should have known that metoclopramide was contraindicated. “It interferes with dopamine receptors in the brain,” the civil claim notice states.
Read more: North Okanagan couple’s access to dock blocked by British Columbia Supreme Court
Read more: Vernon property owner sues city over refusal to issue business license
